Hostname: page-component-cd9895bd7-8ctnn Total loading time: 0 Render date: 2024-12-26T13:37:57.108Z Has data issue: false hasContentIssue false
  • English
  • Français

Systematic review and meta-analysis of vagus nerve stimulation in the treatment of depression: Variable results based on study designs

Published online by Cambridge University Press:  15 April 2020

J.L.R. Martin  and
E. Martín-Sánchez
J.L.R. Martin*
Affiliation:
School of Biomedical and Health Sciences, Universidad Europea de Madrid, Madrid, Spain
E. Martín-Sánchez
Affiliation:
Clinical Research Department, Health and Social Care Foundation of Castilla, La Mancha, Spain
*
*Corresponding author. School of biomedical and Health Sciences, Universidad Europea de Madrid C/ Tajo, s/n 28670, Villaviciosa de Odón, Madrid, Spain. E-mail: [email protected] (J.L.R. Martin).
Get access

Abstract

Purpose:

To determine the efficacy of vagus nerve stimulation (VNS) for treatment of depression.

Methods:

We conducted a systematic review and meta-analysis of analytical studies. Efficacy was evaluated according to severity of illness and percentage of responders.

Results:

We identified 687 references. Of these, 14 met the selection criteria and were included in the review. The meta-analysis of efficacy for uncontrolled studies showed a significant reduction in scores at the Hamilton Depression Rating Scale endpoint, and the percentage of responders was 31.8% ([23.2% to 41.8%], P<0.001). However, the randomised control trial which covered a sample of 235 patients with depression, reported no statistically significant differences between the active intervention and placebo groups (OR=1.61 [95%CI 0.72 to 3.62]; P = 0.25). To study the cause of this heterogeneity, a meta-regression was performed. The adjusted coefficient of determination (R2Adj) was 0.84, which implies that an 84% variation in effect size across the studies was explained by baseline severity of depression (P<0.0001).

Conclusion:

Currently, insufficient data are available to describe VNS as effective in the treatment of depression. In addition, it cannot be ruled out that the positive results observed in the uncontrolled studies might have been mainly due to a placebo effect.

Keywords

Vagus nerve stimulationVNSDepressionSystematic reviewMeta-analysis
Type
Review
Information
European Psychiatry , Volume 27 , Issue 3 , April 2012 , pp. 147 - 155
Copyright
Copyright © Elsevier Masson SAS 2012

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Footnotes

1

Área de Investigación Clínica, Fundación Sociosanitaria de Castilla-La Mancha, C/ Huérfanos Cristinos, 5; 3 drcha, 45003 – Toledo, Castilla-La Mancha, Spain.

References

Adrienne, E., Dorr, A.E., Debonnel, G.Effect of vagus nerve stimulation on serotonergic and noradrenergic transmission. J Pharmacol Exp Ther. 2006; 318: 890–898.Google Scholar
Bajbouj, M., Merkl, A., Schlaepfer, T.E., Frick, C., Zobel, A., Maier, W.et al.Two-year outcome of vagus nerve stimulation in treatment-resistant depression. J Clin Psychopharmacol. 30 3: 2010 273–281.10.1097/JCP.0b013e3181db8831CrossRefGoogle ScholarPubMed
Becker, B.J.Synthesizing standardized mean-change measures. Br J Math Stat Psychol. 1988; 41: 257–278.10.1111/j.2044-8317.1988.tb00901.xCrossRefGoogle Scholar
Brown, E.G., Wood, L., Wood, S.The medical dictionary for regulatory activities (MedDRA). Drug Saf. 20 2: 1999 109–117.10.2165/00002018-199920020-00002CrossRefGoogle ScholarPubMed
Carpenter, W.T. Jr.Placebo effect in depression. Am J Psychiatry. 166 8: 2009 935.10.1176/appi.ajp.2009.09030385CrossRefGoogle ScholarPubMed
Chavel, S.M., Westerveld, M., Spencer, S.Long-term outcome of vagus nerve stimulation for refractory partial epilepsy. Epilepsy Behav. 4 3: 2003 302–309.10.1016/S1525-5050(03)00109-4CrossRefGoogle ScholarPubMed
Cipriani, A., La, F.T., Furukawa, T.A., Signoretti, A., Nakagawa, A., Churchill, R.et al.Sertraline versus other antidepressive agents for depression. Cochrane Database Syst Rev. 2: 2009 CD006117.Google ScholarPubMed
Cipriani, A., Santilli, C., Furukawa, T.A., Signoretti, A., Nakagawa, A., McGuire, H.et al.Escitalopram versus other antidepressive agents for depression. Cochrane Database Syst Rev. 2: 2009 CD006532.Google ScholarPubMed
Cohen, L.J., Allen, J.C. Jr.Estimating the potential savings with vagus nerve stimulation for treatment-resistant depression: a payer perspective. Curr Med Res Opin. 24 8: 2008 2203–2217.10.1185/03007990802229050CrossRefGoogle ScholarPubMed
Comprehensive Meta-Analysis. Version 2.2.048 [computer program]. USA: 2008.Google Scholar
Daban, C., Martinez-Aran, A., Cruz, N., Vieta, E.Safety and efficacy of Vagus Nerve Stimulation in treatment-resistant depression. A systematic review. J Affect Disord. 110 1–2: 2008 1–15.CrossRefGoogle ScholarPubMed
Dunlap, WPCJMVJBBM.J.Meta-analysis of experiments with matched groups or repeated measures designs. Psychol Methods. 1996; 1: 170–177.10.1037/1082-989X.1.2.170CrossRefGoogle Scholar
Egger, M., Smith, G.D., Altman, D.G.Systematic reviews in health care. Meta-analysis in context. 2nd edCornwall: Bodmin; 2001.CrossRefGoogle Scholar
Elger, G., Hoppe, C., Falkai, P., Rush, A.J., Elger, C.E.Vagus nerve stimulation is associated with mood improvements in epilepsy patients. Epilepsy Res. 42 2–3: 2000 203–210.10.1016/S0920-1211(00)00181-9CrossRefGoogle ScholarPubMed
Fekadu, A., Wooderson, S.C., Markopoulo, K., Donaldson, C., Papadopoulos, A., Cleare, A.J.What happens to patients with treatment-resistant depression? A systematic review of medium to long-term outcome studies. J Affect Disord. 116 1–2: 2009 4–11.CrossRefGoogle ScholarPubMed
Gaynes, B.N.Identifying difficult-to-treat depression: differential diagnosis, subtypes, and comorbidities. J Clin Psychiatry. 70 suppl. 6: 2009 10–15.10.4088/JCP.8133su1c.02CrossRefGoogle ScholarPubMed
George, M.S., Rush, A.J., Marangell, L.B., Sackeim, H.A., Brannan, S.K., Davis, S.M.et al.A one-year comparison of vagus nerve stimulation with treatment as usual for treatment-resistant depression. Biol Psychiatry. 58 5: 2005 364–373.CrossRefGoogle ScholarPubMed
Hallbook, T., Lundgren, J., Stjernqvist, K., Blennow, G., Stromblad, L.G., Rosen, I.Vagus nerve stimulation in 15 children with therapy resistant epilepsy; its impact on cognition, quality of life, behaviour and mood. Seizure. 14 7: 2005 504–513.CrossRefGoogle Scholar
Harden, C.L., Pulver, M.C., Ravdin, L.D., Nikolov, B., Halper, J.P., Labar, D.R.A pilot study of mood in epilepsy patients treated with vagus nerve stimulation. Epilepsy Behav. 1 2: 2000 93–99.CrossRefGoogle ScholarPubMed
Harris, A.D., Bradham, D.D., Baumgarten, M., Zuckerman, I.H., Fink, J.C., Perencevich, E.N.The use and interpretation of quasi-experimental studies in infectious diseases. Antimicrob Resist. 2004; 38: 1586–1591.Google ScholarPubMed
Higgins, J.P., Thompson, S.G., Deeks, J.J., Altman, D.G.Measuring inconsistency in meta-analyses. BMJ. 327 7414: 2003 557–560.10.1136/bmj.327.7414.557CrossRefGoogle ScholarPubMed
Hoppe, C., Helmstaedter, C., Scherrmann, J., Elger, C.E.Self-reported mood changes following 6 months of vagus nerve stimulation in epilepsy patients. Epilepsy Behav. 2 4: 2001 335–342.CrossRefGoogle ScholarPubMed
Jadad, A.R., Moore, R.A., Carroll, D., Jenkinson, C., Reynolds, D.J., Gavaghan, D.J.et al.Assessing the quality of reports of randomized clinical trials: is blinding necessary?. Control Clin Trials. 17 1: 1996 1–12.10.1016/0197-2456(95)00134-4CrossRefGoogle ScholarPubMed
Kennedy, S.H., Giacobbe, P.Treatment resistant depression--advances in somatic therapies. Ann Clin Psychiatry. 19 4: 2007 279–287.CrossRefGoogle ScholarPubMed
Kessler, R.C., Berglund, P., Demler, O., Jin, R., Koretz, D., Merikangas, K.R.et al.The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R). JAMA. 289 23: 2003 3095–3105.10.1001/jama.289.23.3095CrossRefGoogle ScholarPubMed
Little, A.Treatment-resistant depression. Am Fam Physician. 80 2: 2009 167–172.Google ScholarPubMed
Marangell, L.B., Suppes, T., Zboyan, H.A., Prashad, S.J., Fischer, G., Snow, D.et al.A 1-year pilot study of vagus nerve stimulation in treatment-resistant rapid-cycling bipolar disorder. J Clin Psychiatry. 69 2: 2008 183–189.10.4088/JCP.v69n0203CrossRefGoogle ScholarPubMed
Mayer, L.S., Bay, R.C., Politis, A., Steinberg, M., Steele, C., Baker, A.S.et al.Comparison of three rating scales as outcome measures for treatment trials of depression in Alzheimer disease: findings from DIADS. Int J Geriatr Psychiatry. 21 10: 2006 930–936.10.1002/gps.1583CrossRefGoogle ScholarPubMed
McCarney, R., Warner, J., Iliffe, S., van, H.R., Griffin, M., Fisher, P.The Hawthorne Effect: a randomised, controlled trial. BMC Med Res Methodol. 2007; 7: 30.CrossRefGoogle ScholarPubMed
McGlone, J., Valdivia, I., Penner, M., Williams, J., Sadler, R.M., Clarke, D.B.Quality of life and memory after vagus nerve stimulator implantation for epilepsy. Can J Neurol Sci. 35 3: 2008 287–296.10.1017/S0317167100008854CrossRefGoogle ScholarPubMed
McGrath, R.E., Meyer, G.J.When effect sizes disagree: the case of r and d. Psychol Methods. 11 4: 2006 386–401.CrossRefGoogle ScholarPubMed
Michaud, C.M., Murray, C.J., Bloom, B.R.Burden of disease--implications for future research. JAMA. 285 5: 2001 535–539.CrossRefGoogle ScholarPubMed
Milby, A.H., Halpern, C.H., Baltuch, G.H.Vagus nerve stimulation for epilepsy and depression. Neurotherapeutics. 5 1: 2008 75–85.CrossRefGoogle ScholarPubMed
Morris, SBDR.P.Combining effect size estimates in meta-analysis with repeated measures and independent-groups designs. Psychol Methods. 2002; 7: 105–125.CrossRefGoogle ScholarPubMed
Nemeroff, C.B.Prevalence and management of treatment-resistant depression. J Clin Psychiatry. 68 suppl. 8: 2007 17–25.Google ScholarPubMed
O’Keane, V., Dinan, T.G., Scott, L., Corcoran, C.Changes in hypothalamic-pituitary-adrenal axis measures after vagus nerve stimulation therapy in chronic depression. Biol Psychiatry. 58 12: 2005 963–968.CrossRefGoogle ScholarPubMed
Rado, J., Janicak, P.G.Vagus nerve stimulation for severe depression. J Psychosoc Nurs Ment Health Serv. 45 7: 2007 43–51.CrossRefGoogle ScholarPubMed
Ramani, R.Vagus nerve stimulation therapy for seizures. J Neurosurg Anesthesiol. 20 1: 2008 29–35.CrossRefGoogle ScholarPubMed
Review Manager (RevMan) version 5.0 [computer program]. Copenhagen: The Cochrane Collaboration; 2008.Google Scholar
Rush, A.J., Siefert, S.E.Clinical issues in considering vagus nerve stimulation for treatment-resistant depression. Exp Neurol. 219 1: 2009 36–43.CrossRefGoogle ScholarPubMed
Rush, A.J., George, M.S., Sackeim, H.A., Marangell, L.B., Husain, M.M., Giller, C.et al.Vagus nerve stimulation (VNS) for treatment-resistant depressions: a multicenter study. Biol Psychiatry. 47 4: 2000 276–286.CrossRefGoogle ScholarPubMed
Rush, A.J., Marangell, L.B., Sackeim, H.A., George, M.S., Brannan, S.K., Davis, S.M.et al.Vagus nerve stimulation for treatment-resistant depression: a randomized, controlled acute phase trial. Biol Psychiatry. 58 5: 2005 347–354.CrossRefGoogle ScholarPubMed
Rush, A.J., Sackeim, H.A., Marangell, L.B., George, M.S., Brannan, S.K., Davis, S.M.et al.Effects of 12 months of vagus nerve stimulation in treatment-resistant depression: a naturalistic study. Biol Psychiatry. 58 5: 2005 355–363.CrossRefGoogle ScholarPubMed
Sackeim, H.A., Rush, A.J., George, M.S., Marangell, L.B., Husain, M.M., Nahas, Z.et al.Vagus nerve stimulation (VNS) for treatment-resistant depression: efficacy, side effects, and predictors of outcome. Neuropsychopharmacology. 25 5: 2001 713–728.CrossRefGoogle ScholarPubMed
Sakas, D.E., Korfias, S., Nicholson, C.L., Panourias, I.G., Georgakoulias, N., Gatzonis, S.et al.Vagus nerve stimulation for intractable epilepsy: outcome in two series combining 90 patients. Acta Neurochir Suppl. 97 Pt 2 2007 287–291.CrossRefGoogle ScholarPubMed
Schachter, S.C.Vagus nerve stimulation therapy summary: five years after FDA approval. Neurology. 59 6 Suppl. 4 2002 S15–S20.CrossRefGoogle ScholarPubMed
Shelton, R.C., Osuntokun, O., Heinloth, A.N., Corya, S.A.Therapeutic options for treatment-resistant depression. CNS Drugs. 24 2: 2010 131–161.CrossRefGoogle ScholarPubMed
Sperling, W., Reulbach, U., Kornhuber, J.Clinical benefits and cost effectiveness of vagus nerve stimulation in a long-term treatment of patients with major depression. Pharmacopsychiatry. 42 3: 2009 85–88.CrossRefGoogle Scholar
Sutton AJ, AKJDSTSF. Methods for Meta- Analysis in Medical Research. Chichester: Wiley series in probability and statistics; 2000.Google Scholar
Wallace, M.Physiology of the placebo effect, and the evidence for changes in brain metabolism. N Z Med J. 123 1312: 2010 54–60.Google ScholarPubMed
Submit a response

Comments

No Comments have been published for this article.